Fig. 6From: The impact of additive or substitutive clinical study design on the negotiated reimbursement for oncology pharmaceuticals after early benefit assessment in GermanyMultiplicative premiums depending on study design and appropriate comparative therapy. Multiplicative premiums are contrasted in box plots depending on study design and appropriate comparative therapyBack to article page